Piramal Pharma Ltd
PPLPHARMA
Pharmaceuticals
₹ 201.90
Price
₹ 26,855
Market Cap
Large Cap
311.14
P/E Ratio
📊 Score Snapshot
5.75 / 25
Performance
15.19 / 25
Valuation
0.0 / 20
Growth
7.0 / 30
Profitability
27.94 / 100
Avoid
🏢 Company Overview
⏳ Loading company overview...
🤖 CARL Insights
⏳ Loading CARL insights...
📈 Net Profit (Yearly)
📊 Sales (Yearly)
📉 Quarterly Sales Trend
📉 Quarterly Net Profit
📈 Yearly Ratios
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Adj Cash EBITDA | 1,154 | 1,194 | 604.00 | 991.00 | 1,018 |
| Adj Cash EBITDA Margin | 12.94 | 15.35 | 8.42 | 15.55 | 17.55 |
| Adj Cash EBITDA To EBITDA | 0.70 | 0.84 | 0.67 | 0.77 | 0.62 |
| Adj Cash EPS | -2.99 | -1.60 | -3.76 | - | - |
| Adj Cash PAT | -394.81 | -221.94 | -495.75 | 73.15 | 231.72 |
| Adj Cash PAT To PAT | -4.24 | -18.40 | 2.56 | 0.20 | 0.27 |
| Adj EPS | 0.71 | 0.09 | -1.47 | - | - |
| Adj EV To Cash EBITDA | 29.30 | 19.49 | 22.36 | - | - |
| Adj EV To EBITDA | 20.59 | 16.30 | 14.91 | - | - |
| Adj Number Of Shares | 131.88 | 138.46 | 131.91 | - | - |
| Adj PE | 326.16 | 1,932 | - | - | - |
| Adj Peg | 0.47 | - | - | - | - |
| Bvps | 61.61 | 57.14 | 51.35 | - | - |
| Cash Conversion Cycle | 182.00 | 174.00 | 159.00 | 153.00 | 147.00 |
| Cash ROCE | -1.17 | -1.07 | -2.02 | -9.57 | - |
| Cash Roic | -1.38 | -1.17 | -5.32 | -11.03 | - |
| Cash Revenue | 8,918 | 7,780 | 7,171 | 6,374 | 5,800 |
| Cash Revenue To Revenue | 0.97 | 0.95 | 1.01 | 0.97 | 0.92 |
| Dio | 261.00 | 269.00 | 227.00 | 207.00 | 218.00 |
| Dpo | 173.00 | 190.00 | 161.00 | 153.00 | 163.00 |
| Dso | 94.00 | 95.00 | 93.00 | 99.00 | 91.00 |
| Dividend Yield | 0.06 | 0.08 | - | - | - |
| EV | 33,807 | 23,275 | 13,507 | - | - |
| EV To EBITDA | 20.72 | 15.65 | 14.83 | - | - |
| Fcfe | -189.81 | -1,163 | 415.25 | -85.85 | -287.28 |
| Fcfe Margin | -2.13 | -14.95 | 5.79 | -1.35 | -4.95 |
| Fcfe To Adj PAT | -2.04 | -96.43 | -2.14 | -0.24 | -0.34 |
| Fcff | -193.06 | -157.13 | -664.40 | -1,189 | -97.05 |
| Fcff Margin | -2.16 | -2.02 | -9.27 | -18.65 | -1.67 |
| Fcff To NOPAT | -1.40 | -3.43 | 8.93 | -4.21 | -0.12 |
| Market Cap | 29,743 | 19,433 | 8,817 | - | - |
| PB | 3.66 | 2.46 | 1.30 | - | - |
| PE | 326.86 | 1,080 | - | - | - |
| Peg | 0.76 | - | - | - | - |
| PS | 3.25 | 2.38 | 1.24 | - | - |
| ROCE | 1.41 | 0.55 | 3.06 | 5.56 | - |
| ROE | 1.16 | 0.16 | -2.88 | 5.94 | - |
| Roic | 0.98 | 0.34 | -0.60 | 2.62 | - |
| Share Price | 225.53 | 140.35 | 66.84 | - | - |
📊 Quarterly Results
| Metric | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,044 | 1,934 | 2,754 | 2,204 | 2,242 | 1,951 | 2,552 | 1,959 | 1,911 | 1,749 | 2,164 | 1,716 | 1,720 | 1,482 |
| Interest | 82.00 | 86.00 | 104.00 | 103.00 | 108.00 | 107.00 | 114.00 | 106.00 | 110.00 | 119.00 | 104.00 | 95.00 | 83.00 | 62.00 |
| Expenses - | 1,885 | 1,827 | 2,193 | 1,866 | 1,900 | 1,747 | 2,022 | 1,690 | 1,646 | 1,617 | 1,812 | 1,629 | 1,547 | 1,465 |
| Other Income - | 80.00 | 77.00 | 58.00 | 29.00 | 78.00 | 42.00 | 38.00 | 75.00 | 68.00 | 53.00 | 32.00 | 98.00 | 57.00 | 92.00 |
| Exceptional Items | - | 21.00 | - | - | - | - | -31.00 | -32.00 | - | - | - | - | -7.00 | - |
| Depreciation | 203.00 | 197.00 | 243.00 | 197.00 | 192.00 | 185.00 | 196.00 | 186.00 | 185.00 | 174.00 | 184.00 | 164.00 | 166.00 | 162.00 |
| Profit Before Tax | -46.00 | -79.00 | 273.00 | 67.00 | 120.00 | -45.00 | 227.00 | 19.00 | 40.00 | -107.00 | 95.00 | -74.00 | -26.00 | -115.00 |
| Tax % | -115.22 | -3.80 | 43.59 | 94.03 | 80.83 | -97.78 | 55.51 | 47.37 | 87.50 | 7.48 | 47.37 | -21.62 | -42.31 | 5.22 |
| Net Profit - | -99.00 | -82.00 | 154.00 | 4.00 | 23.00 | -89.00 | 101.00 | 10.00 | 5.00 | -99.00 | 50.00 | -90.00 | -37.00 | -109.00 |
| Exceptional Items At | - | - | - | - | - | - | -14.00 | 1.00 | - | - | - | - | 1.00 | - |
| Profit Excl Exceptional | -99.00 | -93.00 | 154.00 | 4.00 | 23.00 | -89.00 | 115.00 | 9.00 | 5.00 | -99.00 | 50.00 | -90.00 | -39.00 | -109.00 |
| Profit For PE | -99.00 | - | 154.00 | 4.00 | 23.00 | -89.00 | 115.00 | 9.00 | 5.00 | -99.00 | 50.00 | -90.00 | -39.00 | -109.00 |
| Profit For EPS | -99.00 | - | 154.00 | 4.00 | 23.00 | -89.00 | 101.00 | 10.00 | 5.00 | -99.00 | 50.00 | -90.00 | -37.00 | -109.00 |
| EPS In Rs | -0.75 | -0.61 | 1.16 | 0.03 | 0.17 | -0.67 | 0.77 | 0.08 | 0.04 | -0.75 | 0.38 | -0.68 | -0.28 | - |
| PAT Margin % | -4.84 | -4.24 | 5.59 | 0.18 | 1.03 | -4.56 | 3.96 | 0.51 | 0.26 | -5.66 | 2.31 | -5.24 | -2.15 | -7.35 |
| PBT Margin | -2.25 | -4.08 | 9.91 | 3.04 | 5.35 | -2.31 | 8.89 | 0.97 | 2.09 | -6.12 | 4.39 | -4.31 | -1.51 | -7.76 |
| Tax | 53.00 | 3.00 | 119.00 | 63.00 | 97.00 | 44.00 | 126.00 | 9.00 | 35.00 | -8.00 | 45.00 | 16.00 | 11.00 | -6.00 |
| Yoy Profit Growth % | -539.00 | -5.00 | 34.00 | -59.00 | 350.00 | 10.00 | 129.00 | 110.00 | 113.00 | 10.00 | -75.00 | -155.00 | -205.00 | - |
| Adj Ebit | 36.00 | -13.00 | 376.00 | 170.00 | 228.00 | 61.00 | 372.00 | 158.00 | 148.00 | 11.00 | 200.00 | 21.00 | 64.00 | -53.00 |
| Adj EBITDA | 239.00 | 184.00 | 619.00 | 367.00 | 420.00 | 246.00 | 568.00 | 344.00 | 333.00 | 185.00 | 384.00 | 185.00 | 230.00 | 109.00 |
| Adj EBITDA Margin | 11.69 | 9.51 | 22.48 | 16.65 | 18.73 | 12.61 | 22.26 | 17.56 | 17.43 | 10.58 | 17.74 | 10.78 | 13.37 | 7.35 |
| Adj Ebit Margin | 1.76 | -0.67 | 13.65 | 7.71 | 10.17 | 3.13 | 14.58 | 8.07 | 7.74 | 0.63 | 9.24 | 1.22 | 3.72 | -3.58 |
| Adj PAT | -99.00 | -60.20 | 154.00 | 4.00 | 23.00 | -89.00 | 87.21 | -6.84 | 5.00 | -99.00 | 50.00 | -90.00 | -46.96 | -109.00 |
| Adj PAT Margin | -4.84 | -3.11 | 5.59 | 0.18 | 1.03 | -4.56 | 3.42 | -0.35 | 0.26 | -5.66 | 2.31 | -5.24 | -2.73 | -7.35 |
| Ebit | 36.00 | -34.00 | 376.00 | 170.00 | 228.00 | 61.00 | 403.00 | 190.00 | 148.00 | 11.00 | 200.00 | 21.00 | 71.00 | -53.00 |
| EBITDA | 239.00 | 163.00 | 619.00 | 367.00 | 420.00 | 246.00 | 599.00 | 376.00 | 333.00 | 185.00 | 384.00 | 185.00 | 237.00 | 109.00 |
| EBITDA Margin | 11.69 | 8.43 | 22.48 | 16.65 | 18.73 | 12.61 | 23.47 | 19.19 | 17.43 | 10.58 | 17.74 | 10.78 | 13.78 | 7.35 |
| Ebit Margin | 1.76 | -1.76 | 13.65 | 7.71 | 10.17 | 3.13 | 15.79 | 9.70 | 7.74 | 0.63 | 9.24 | 1.22 | 4.13 | -3.58 |
| NOPAT | -94.70 | -93.42 | 179.38 | 8.42 | 28.75 | 37.58 | 148.60 | 43.68 | 10.00 | -38.86 | 88.42 | -93.65 | 9.96 | -137.43 |
| NOPAT Margin | -4.63 | -4.83 | 6.51 | 0.38 | 1.28 | 1.93 | 5.82 | 2.23 | 0.52 | -2.22 | 4.09 | -5.46 | 0.58 | -9.27 |
| Operating Profit | -44.00 | -90.00 | 318.00 | 141.00 | 150.00 | 19.00 | 334.00 | 83.00 | 80.00 | -42.00 | 168.00 | -77.00 | 7.00 | -145.00 |
| Operating Profit Margin | -2.15 | -4.65 | 11.55 | 6.40 | 6.69 | 0.97 | 13.09 | 4.24 | 4.19 | -2.40 | 7.76 | -4.49 | 0.41 | -9.78 |
💰 Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Sales | 9,151 | 8,171 | 7,082 | 6,559 | 6,315 |
| Interest | 422.00 | 448.00 | 344.00 | 198.00 | 163.00 |
| Expenses - | 7,706 | 6,974 | 6,453 | 5,609 | 4,887 |
| Other Income - | 197.00 | 231.00 | 277.00 | 333.00 | 210.00 |
| Exceptional Items | 10.00 | -59.00 | -5.00 | -14.00 | 19.00 |
| Depreciation | 816.00 | 741.00 | 677.00 | 586.00 | 545.00 |
| Profit Before Tax | 415.00 | 179.00 | -120.00 | 485.00 | 949.00 |
| Tax % | 78.07 | 89.94 | -55.00 | 22.47 | 12.01 |
| Net Profit - | 91.00 | 18.00 | -186.00 | 376.00 | 835.00 |
| Exceptional Items At | 2.00 | 2.00 | - | -8.00 | 17.00 |
| Profit Excl Exceptional | 89.00 | 16.00 | -186.00 | 384.00 | 818.00 |
| Profit For PE | 89.00 | 16.00 | -186.00 | 384.00 | 818.00 |
| Profit For EPS | 91.00 | 18.00 | -186.00 | 376.00 | 835.00 |
| EPS In Rs | 0.69 | 0.13 | -1.41 | - | - |
| Dividend Payout % | 20.00 | 82.00 | - | 18.00 | - |
| PAT Margin % | 0.99 | 0.22 | -2.63 | 5.73 | 13.22 |
| PBT Margin | 4.54 | 2.19 | -1.69 | 7.39 | 15.03 |
| Tax | 324.00 | 161.00 | 66.00 | 109.00 | 114.00 |
| Adj Ebit | 826.00 | 687.00 | 229.00 | 697.00 | 1,093 |
| Adj EBITDA | 1,642 | 1,428 | 906.00 | 1,283 | 1,638 |
| Adj EBITDA Margin | 17.94 | 17.48 | 12.79 | 19.56 | 25.94 |
| Adj Ebit Margin | 9.03 | 8.41 | 3.23 | 10.63 | 17.31 |
| Adj PAT | 93.19 | 12.06 | -193.75 | 365.15 | 851.72 |
| Adj PAT Margin | 1.02 | 0.15 | -2.74 | 5.57 | 13.49 |
| Ebit | 816.00 | 746.00 | 234.00 | 711.00 | 1,074 |
| EBITDA | 1,632 | 1,487 | 911.00 | 1,297 | 1,619 |
| EBITDA Margin | 17.83 | 18.20 | 12.86 | 19.77 | 25.64 |
| Ebit Margin | 8.92 | 9.13 | 3.30 | 10.84 | 17.01 |
| NOPAT | 137.94 | 45.87 | -74.40 | 282.21 | 776.95 |
| NOPAT Margin | 1.51 | 0.56 | -1.05 | 4.30 | 12.30 |
| Operating Profit | 629.00 | 456.00 | -48.00 | 364.00 | 883.00 |
| Operating Profit Margin | 6.87 | 5.58 | -0.68 | 5.55 | 13.98 |
🏦 Balance Sheet
| Metric | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Sep 2023 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | - | 4,943 | - | 4,110 | - | 3,374 | 2,631 | 2,047 |
| Advance From Customers | - | 223.00 | - | 344.00 | - | 117.00 | 140.00 | 72.00 |
| Average Capital Employed | 12,810 | 12,802 | 12,493 | 12,516 | - | 11,618 | 9,728 | - |
| Average Invested Capital | 11,964 | 14,008 | 11,754 | 13,379 | - | 12,500 | 10,779 | - |
| Average Total Assets | 15,716 | 15,256 | 15,009 | 14,693 | - | 13,454 | 11,641 | - |
| Average Total Equity | 7,990 | 8,018 | 7,832 | 7,342 | - | 6,735 | 6,151 | - |
| Cwip | 567.00 | 977.00 | 621.00 | 1,116 | 989.00 | 1,419 | 1,172 | 627.00 |
| Capital Employed | 12,925 | 12,982 | 12,694 | 12,622 | 12,292 | 12,411 | 10,825 | 8,630 |
| Cash Equivalents | 522.00 | 501.00 | 398.00 | 483.00 | 536.00 | 308.00 | 329.00 | 406.00 |
| Fixed Assets | 8,827 | 8,133 | 8,475 | 7,990 | 8,049 | 7,469 | 6,879 | 6,105 |
| Gross Block | - | 13,077 | - | 12,099 | - | 10,842 | 9,510 | 8,153 |
| Inventory | 2,743 | 2,313 | 2,447 | 2,176 | 2,060 | 1,681 | 1,389 | 1,232 |
| Invested Capital | 11,895 | 14,314 | 12,032 | 13,702 | 11,477 | 13,056 | 11,944 | 9,614 |
| Investments | 442.00 | 291.00 | 241.00 | 385.00 | 278.00 | 639.00 | 267.00 | 123.00 |
| Lease Liabilities | 136.00 | 136.00 | 143.00 | 151.00 | 130.00 | 132.00 | 105.00 | 115.00 |
| Loans N Advances | 67.00 | 226.00 | 22.00 | 186.00 | - | 208.00 | 70.00 | 63.00 |
| Long Term Borrowings | 3,317 | 3,214 | 1,535 | 2,484 | 2,861 | 3,384 | 2,622 | 2,339 |
| Net Debt | 3,887 | 4,064 | 4,147 | 3,842 | 3,720 | 4,690 | 3,532 | 2,496 |
| Net Working Capital | 2,501 | 5,204 | 2,936 | 4,596 | 2,439 | 4,168 | 3,893 | 2,882 |
| Other Asset Items | 1,037 | 638.00 | 1,210 | 613.00 | 1,120 | 781.00 | 714.00 | 547.00 |
| Other Liability Items | 1,436 | 690.00 | 1,212 | 579.00 | 1,023 | 582.00 | 614.00 | 1,057 |
| Reserves | 6,748 | 6,801 | 6,584 | 6,588 | 6,435 | 5,580 | 5,511 | 4,610 |
| Share Capital | 1,326 | 1,324 | 1,323 | 1,323 | 1,323 | 1,193 | 1,186 | 995.00 |
| Short Term Borrowings | 1,399 | 1,506 | 3,108 | 2,075 | 1,543 | 2,121 | 1,401 | 571.00 |
| Total Assets | 16,189 | 15,429 | 15,242 | 15,083 | 14,776 | 14,303 | 12,605 | 10,677 |
| Total Borrowings | 4,851 | 4,856 | 4,786 | 4,710 | 4,534 | 5,637 | 4,128 | 3,025 |
| Total Equity | 8,074 | 8,125 | 7,907 | 7,911 | 7,758 | 6,773 | 6,697 | 5,605 |
| Total Equity And Liabilities | 16,189 | 15,429 | 15,242 | 15,083 | 14,776 | 14,303 | 12,605 | 10,677 |
| Total Liabilities | 8,115 | 7,304 | 7,335 | 7,172 | 7,018 | 7,530 | 5,908 | 5,072 |
| Trade Payables | 1,828 | 1,534 | 1,336 | 1,538 | 1,461 | 1,193 | 1,026 | 918.00 |
| Trade Receivables | 1,985 | 4,700 | 1,827 | 4,268 | 1,743 | 3,598 | 3,570 | 3,150 |
💵 Cash Flows
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Cash From Financing Activity | -441.00 | -422.00 | 818.00 | 794.00 | 3,977 |
| Cash From Investing Activity | -488.00 | -416.00 | -1,334 | -1,737 | -4,464 |
| Cash From Operating Activity | 892.00 | 1,005 | 484.00 | 766.00 | 598.00 |
| Cash Paid For Acquisition Of Companies | - | - | - | -805.00 | -197.00 |
| Cash Paid For Investment In Subsidaries And Associates | - | - | -20.00 | -102.00 | - |
| Cash Paid For Purchase Of Fixed Assets | -664.00 | -712.00 | -965.00 | -890.00 | -602.00 |
| Cash Paid For Purchase Of Investments | -1,874 | -1,671 | -1,209 | -1,454 | -6.00 |
| Cash Paid For Repayment Of Borrowings | -1,065 | -1,212 | -3,186 | -1,234 | -2,812 |
| Cash Received From Borrowings | 1,113 | 240.00 | 4,385 | 2,254 | 2,547 |
| Cash Received From Issue Of Shares | - | 1,050 | - | - | 3,448 |
| Cash Received From Sale Of Fixed Assets | 5.00 | 2.00 | 20.00 | 32.00 | - |
| Cash Received From Sale Of Investments | 1,999 | 1,943 | 834.00 | 1,403 | - |
| Change In Inventory | -197.00 | -532.00 | -173.00 | -176.00 | -89.00 |
| Change In Other Working Capital Items | -75.00 | 285.00 | 53.00 | -11.00 | -160.00 |
| Change In Payables | 18.00 | 404.00 | -272.00 | 79.00 | 146.00 |
| Change In Receivables | -233.00 | -391.00 | 89.00 | -185.00 | -515.00 |
| Change In Working Capital | -488.00 | -234.00 | -302.00 | -292.00 | -620.00 |
| Direct Taxes Paid | -334.00 | -157.00 | -189.00 | -169.00 | -145.00 |
| Dividends Paid | -14.00 | - | -67.00 | -50.00 | - |
| Dividends Received | 46.00 | 22.00 | 75.00 | 82.00 | 49.00 |
| Interest Paid | -447.00 | -470.00 | -278.00 | -145.00 | -4.00 |
| Interest Received | - | - | - | 1.00 | 4.00 |
| Net Cash Flow | -37.00 | 166.00 | -32.00 | -177.00 | 110.00 |
| Other Cash Financing Items Paid | -28.00 | -31.00 | -36.00 | -30.00 | 798.00 |
| Other Cash Investing Items Paid | -1.00 | - | -68.00 | -5.00 | -3,712 |
| Profit From Operations | 1,714 | 1,396 | 975.00 | 1,228 | 1,362 |
🧾 Shareholding Pattern
| Nse Code | Date | Promoters | Fii | Dii | Public | Others |
|---|---|---|---|---|---|---|
| Pplpharma | 2025-09-30 | - | 30.27 | 14.89 | 19.46 | 0.51 |
| Pplpharma | 2025-06-30 | - | 30.86 | 14.25 | 19.46 | 0.57 |
| Pplpharma | 2025-03-31 | - | 31.49 | 14.78 | 18.42 | 0.34 |
| Pplpharma | 2024-12-31 | - | 31.68 | 14.09 | 18.85 | 0.40 |
💬
Stock Chat